Mercedes Vazquez Chantada

Director Cell High Throughput Screening (Hts) @AstraZeneca

Cambridge, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Oct 2022 — Present

Director Cell High Throughput Screening (Hts) @AstraZeneca

View department →

Cambridgeshire, GB

Cell High Throughput Screening (HTS)

EDUCATION

1999 — 2004

Universidad de Santiago de Compostela

Licenciado / Bachelor, Master of Science in Molecular Biology and Biotechnology.

2007 — 2007

Duke University

Visiting PhD Student

2004 — 2009

EHU

PhD., PhD in Biochemistry and Molecular Biology

2006 — 2006

The Johns Hopkins University

Visiting PhD Student, NIH (NIA)

SKILLS

Biomarker DiscoveryEmbryonic Stem CellsCell Based AssaysCell CultureClinical ResearchCell BiologyCancer ResearchGene SilencingGcpImmunohistochemistryGlpLife SciencesFlow CytometryImmunofluorescenceGenomicsTransfectionProject ManagementR&DMetabolomicsGeneticsElisaHigh Content ScreeningCrispr-Cas9 Genome EditingLifesciencesAnimal ModelsCommunicationMolecular BiologyPcrInduced Pluripoten Stem Cells (Ips)Next Generation SequencingBiochemistryBiotechnologySnp GenotypingIn Vitro DiagnosticsData AnalysisDrug Discovery

ABOUT MERCEDES VAZQUEZ CHANTADA

Director at AstraZeneca

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Mercedes Vazquez Chantada — Director Cell High Throughput Screening (Hts) at AstraZeneca in Cambridge, GB | Unifers